Cases & Deals

Share

Artis BioSolutions acquires Syngoi Technologies

January 2026

Client(s) Artis Biosolutions

Jones Day is representing Artis Biosolutions, a San-Diego based advanced-therapies development and manufacturing company, in its acquisition of Syngoi Technologies, a Spanish biotechnology company pioneering novel enzymatic approaches for manufacturing synthetic DNA technologies.

The transaction is expected to close in the first quarter of 2026, subject to regulatory clearances and other customary closing conditions.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.